Standout Papers
- Cetuximab-Induced Anaphylaxis and IgE Specific for Galactose-α-1,3-Galactose (2008)
- Nivolumab monotherapy in recurrent metastatic urothelial carcinoma (CheckMate 032): a multicentre, open-label, two-stage, multi-arm, phase 1/2 trial (2016)
- Phase II Pilot Study of Vemurafenib in Patients With Metastatic BRAF -Mutated Colorectal Cancer (2015)
Immediate Impact
9 by Nobel laureates 28 from Science/Nature 58 standout
Citing Papers
Targeting KRAS in cancer
2024 Standout
Encorafenib Plus Cetuximab as a New Standard of Care for Previously Treated BRAF V600E–Mutant Metastatic Colorectal Cancer: Updated Survival Results and Subgroup Analyses from the BEACON Study
2021 Standout
Works of Emily Chan being referenced
Phase II Pilot Study of Vemurafenib in Patients With Metastatic BRAF -Mutated Colorectal Cancer
2015 Standout
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Emily Chan | 2068 | 1348 | 1669 | 90 | 4.7k | |
| Francis Y. Lee | 1707 | 649 | 2346 | 102 | 7.2k | |
| Bronislaw Pytowski | 3527 | 1080 | 3433 | 61 | 6.4k | |
| Sufi M. Thomas | 2151 | 420 | 2616 | 101 | 5.1k | |
| H. Baisch | 1548 | 688 | 1931 | 57 | 5.5k | |
| Maria Flavia Di Renzo | 1906 | 1344 | 4032 | 105 | 7.3k | |
| Jerry Ware | 1015 | 1057 | 1942 | 146 | 8.2k | |
| Kenneth E. Lipson | 1236 | 516 | 3261 | 119 | 6.1k | |
| G. David Roodman | 5156 | 758 | 3054 | 129 | 7.5k | |
| Pipsa Saharinen | 2509 | 539 | 3454 | 68 | 6.3k | |
| G. Kenneth Haines | 2138 | 679 | 2029 | 91 | 6.5k |
All Works
Login with ORCID to disown or claim papers
Loading papers...